![OncLive](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/836/normal/Screen_Shot_2017-10-24_at_17.05.10.png?1508861154)
Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy
OncLive,
Over 180,000 people are diagnosed with multiple myeloma (MM) globally every year, and these patients and their loved ones face…
Over 180,000 people are diagnosed with multiple myeloma (MM) globally every year, and these patients and their loved ones face…
Abstract Background In recent years, several bispecific antibodies (BsAbs) have been introduced that revolutionized the…